[
  {
    "ts": null,
    "headline": "Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy",
    "summary": "Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth potential. Click for this CRSP update.",
    "url": "https://finnhub.io/api/news?id=0c0fd8fef65b190bf9c8395f52f646fd5a20fb1ef943bb2877d45e24b9f1f0de",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764844190,
      "headline": "Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy",
      "id": 137680924,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2196575232/image_2196575232.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth potential. Click for this CRSP update.",
      "url": "https://finnhub.io/api/news?id=0c0fd8fef65b190bf9c8395f52f646fd5a20fb1ef943bb2877d45e24b9f1f0de"
    }
  },
  {
    "ts": null,
    "headline": "3 Cash-Producing Stocks We Find Risky",
    "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
    "url": "https://finnhub.io/api/news?id=17a092507a001d223e3ba9ad17c5150d686a122366b51bbaad29bfa7ea7dbef9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764822832,
      "headline": "3 Cash-Producing Stocks We Find Risky",
      "id": 137680269,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
      "url": "https://finnhub.io/api/news?id=17a092507a001d223e3ba9ad17c5150d686a122366b51bbaad29bfa7ea7dbef9"
    }
  }
]